Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases

This publication has 12 references indexed in Scilit:

• EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
  The EMBO Journal, 2003
• EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
  Proceedings of the National Academy of Sciences, 2003
• Chromatin Remodeling and Cancer
  Cancer Biology & Therapy, 2003
• The EZH2 polycomb transcriptional repressor—a marker or mover of metastatic prostate cancer?
  Cancer Cell, 2002
• Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
  Science, 2002
• The polycomb group protein EZH2 is involved in progression of prostate cancer
  Nature, 2002
• Distinct BMI-1 and EZH2 Expression Patterns in Thymocytes and Mature T Cells Suggest a Role for Polycomb Genes in Human T Cell Differentiation
  The Journal of Immunology, 2001
• Coexpression of BMI-1 and EZH2 Polycomb Group Genes in Reed-Sternberg Cells of Hodgkin’s Disease
  The American Journal of Pathology, 2000
• The human EZH2 gene: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders
  European Journal of Human Genetics, 2000
• Cloning of a Human Homolog of theDrosophila Enhancer of zesteGene (EZH2) That Maps to Chromosome 21q22.2
  Genomics, 1996